Regenerative Therapy
Engineered bone-targeting particles reduced bone loss in mice
Weekly doses of particles carrying instructions for making the bone-building drug teriparatide improved spongy bone structure in a mouse model of osteoporosis.Weekly doses of particles carrying instructions for making the bone-building drug teriparatide improved spongy bone structure in a mouse model of osteoporosis.
Mouse studyBone loss
Who was studiedMice with induced osteoporosis
What changedWeekly doses of bone-targeting particles reduced bone loss and improved spongy bone structure in mice with osteoporosis
The catchEfficacy measures covered bone structure and formation, not bone strength or fractures